MEDIPART ApS: Financial statements 2023
CVR: 28895399
Source: annual report 2023, Danish Business Authority
01/08/2022 – 31/07/2023
MEDIPART ApS (CVR 28895399) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -705,891 and a net result of DKK -1,522,856 compared with DKK 861,558 the year before. Equity in the 2023 report amounted to DKK 11,510,068. The solvency ratio was 99.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -705,891
- Profit/Loss
- DKK -1,522,856
- Equity
- DKK 11,510,068
- Total Assets
- DKK 11,589,132
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -706 t. | -1.5 mio. | 11.5 mio. | 1 |
| 2022 | - | -155 t. | 862 t. | 13 mio. | 1 |
| 2021 | - | 7.6 mio. | 5.6 mio. | 12.2 mio. | 1 |
| 2020 | - | 8 t. | -373 t. | 6.5 mio. | 1 |
| 2019 | - | 1.3 mio. | 852 t. | 6.9 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout MEDIPART ApS
MEDIPART ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Rikke Nygaard. The company is owned by Erik Nygaard. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -64,509 and a net result of DKK 138,106 compared with DKK 4,660 the year before. Equity in the 2025 report amounted to DKK 11,652,834.